GENETHERA INC
company.status.inactiveCIK 1017110fmd_1FVT58G3KTX1AK27PM646W3PJSManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2010 to Sep 30, 2022, 50 periods
| Line item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | – | – | – | – | – | – | – | – | – |
| Realized investment gains (losses) | – | – | – | (0) | 0 | – | – | – | – | – |
| Compensation and benefits | 0 | 0 | 0 | 0 | 1 | – | – | – | – | – |
| Total operating expenses | 2 | 1 | 1 | 1 | 1 | 1 | 4 | 1 | 1 | 1 |
| Operating income | (2) | (1) | (1) | (1) | (1) | (1) | (4) | (1) | (1) | (1) |
| Interest expense | 0 | – | 0 | (0) | (0) | 0 | 0 | 0 | 0 | 0 |
| Interest and investment income | – | – | – | – | – | 0 | 1 | – | 0 | 0 |
| Other non-operating income (expense) | (0) | 0 | – | – | 0 | – | – | – | – | – |
| Income before taxes | – | – | – | (1) | (1) | (1) | (3) | (1) | (1) | (1) |
| Income tax expense | – | – | – | 0 | 0 | – | – | – | 0 | 0 |
| Net income from continuing operations | (2) | (1) | (1) | (1) | (1) | – | – | – | (1) | (1) |
| Net income | (2) | (1) | (1) | (1) | (1) | (1) | (3) | (1) | (1) | (1) |
| Net income to common shareholders | – | – | – | (1) | (1) | – | – | – | – | – |